Scientific Co-Founder/Clinical Advisor
Praesidia Biotherapeutics
Praesidias utilizes a targeted delivery platform to facilitate the transport of therapeutics across the blood-brain barrier, enhancing the efficacy of treatments for neurological conditions. This technology enables organ- and cell-specific delivery, improving therapeutic windows and patient outcomes.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$11.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Praesidias utilizes a targeted delivery platform to facilitate the transport of therapeutics across the blood-brain barrier, enhancing the efficacy of treatments for neurological conditions. This technology enables organ- and cell-specific delivery, improving therapeutic windows and patient outcomes.